B

Active Director Director DIN 08888108
DIN 08888108 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Bharti

Data last updated:

Bharti is a Director at Vaxicare Enterprises Private Limited (since 2020). The company operates in Pharma. Vaxicare Enterprises Private Limited reported revenue of ₹9.51 Cr (FY 2022).

DIN 08888108
Primary Designation Director
Industry Pharma
First Appointment 21 Sep 2020
Oldest Company Age 7 yrs
Largest company Vaxicare Enterprises Private Limited · ₹9.51 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vaxicare Enterprises Private Limited U51909DL2019PTC348758
Director21 Sep 20202019₹9.51 Cr (FY 2022)Active

Board colleagues of Bharti

NameDINCompanyDesignation
Manoj Nailwal08423981Vaxicare Enterprises Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vaxicare Enterprises Private Limited
Premium access

Shareholding and investment profile for Bharti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharti

Bharti currently holds 1 directorship: Vaxicare Enterprises Private Limited (Director, since 21 Sep 2020, revenue ₹9.51 Cr (FY 2022)).

Bharti was first appointed on 21 Sep 2020 as Director at Vaxicare Enterprises Private Limited.

The current boards of Bharti's companies include Manoj Nailwal (Vaxicare Enterprises Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available